CervoMed CRVO
NASDAQ CRVO
$2.31 +0.07 (+3.12%)
At close: Oct 23, 2026 · 4:00 PM EDT

CervoMed (CRVO) Gains from Investment Securities (2012 - 2026)

Updated

Analysis

CervoMed (CRVO) Gains from Investment Securities (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 CervoMed 23.66 Mn -62.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 314.00
Mar 31, 2026 -6,024.00
Jun 30, 2025 -22,006.00
Mar 31, 2025 -34,974.00
Jun 30, 2024 19,702.00
Jun 30, 2023 32,252.00
Mar 31, 2023 -32,252.00
Dec 31, 2022 51,580.00
Sep 30, 2022 -173,538.00
Jun 30, 2022 36,925.00
Mar 31, 2022 49,658.00
Dec 31, 2013 226,437.00
Jun 30, 2013 1.41 Mn
Mar 31, 2013 -236,850.00
Sep 30, 2012 -15.87 Mn
Mar 31, 2012 2.05 Mn
API Access

CervoMed Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CRVO&period=max&api_key=YOUR_API_KEY